Home » Topics » BioWorld Science

BioWorld Science
RSS

New use for 5-HT2 antagonist

Sep. 20, 1996

Troglitazone nearing launch

Sep. 20, 1996

New indications discovered for Ligand's retinoid compound, Targretin

Sep. 20, 1996

Clinical trials with Gilead Sciences' GS-840

Sep. 20, 1996

Prokinetic macrolides reported by Abbott

Sep. 20, 1996

Second pivotal trial for Carrington's ulcerative colitis product

Sep. 20, 1996

Novel proton pump inhibitors from Dainippon

Sep. 20, 1996

NC-1800 advances through clinical trials

Sep. 20, 1996

New agents for BPH from Abbott

Sep. 20, 1996

Merck & Co. continues to investigate 5alpha-reductase inhibitors

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 14, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026